Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
36.75 HKD | +3.23% | +1.52% | -25.15% |
04-30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
04-29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.